Fundz

Catalyst Pharmaceuticals Appoints Will T. Andrews as Chief Medical Officer

TAKEN PRIVATEJun 02, 2025

Position

Chief Medical Officer

Company

Catalyst Pharmaceuticals

William (Will) T. Andrews
Coral GablesBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Catalyst Pharmaceuticals has announced the appointment of Dr. William T. Andrews as Chief Medical Officer

Quick answer

Catalyst Pharmaceuticals Appoints Will T. Andrews as Chief Medical Officer (June 2, 2025). Catalyst Pharmaceuticals is based in Coral Gables, Florida, United States.

Who is the new Chief Medical Officer at Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals named William (Will) T. Andrews Chief Medical Officer, announced June 2, 2025.
What did Catalyst Pharmaceuticals announce on June 2, 2025?
Catalyst Pharmaceuticals has announced the appointment of Dr. William T. Andrews as Chief Medical Officer
What does Catalyst Pharmaceuticals do?
On July 18, 2023 Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals.
Where is Catalyst Pharmaceuticals based?
Catalyst Pharmaceuticals is based in Coral Gables, Florida, United States.

Source: Fundz verified event record.

Who to call at Catalyst Pharmaceuticals, and when

A new leader at Catalyst Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Catalyst Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Catalyst Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Catalyst Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Catalyst Pharmaceuticals

Location

Coral Gables, Florida, United States

About

On July 18, 2023 Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals. At Catalyst Pharmaceuticals, we understand that receiving a rare disease diagnosis can be extremely difficult. Often patients feel isolated and hopeless. That’s why we believe that, when you’re battling a rare disease—it’s all about the company you keep.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Catalyst Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Catalyst Pharmaceuticals's next move

Learn about Strategic plan

Catalyst Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.